On Verge of Merger, NitroMed Sells Technology in $7.8M Deal April 24, 2009 By Catherine Hollingsworth No Comments
NewCo News: Archer Pharma Working on New Version of AD Drug April 23, 2009 By Catherine Hollingsworth No Comments
Medarex Sharing up to $225M from Antibody Deal with Merck April 22, 2009 By Catherine Hollingsworth No Comments A combination of monoclonal antibodies co-developed by Medarex Inc. and Massachusetts Biologic Laboratories has been licensed to drug giant Merck & Co. Inc. in a deal worth up to $225M. (BioWorld Today)Read More
Discovery Labs Shares Fall as FDA Delays Surfaxin Decision April 21, 2009 By Catherine Hollingsworth No Comments
Pharmacyclics, French Firm in $39.5M HDAC Drug Deal April 20, 2009 By Catherine Hollingsworth No Comments
Synageva Raises $30M to Advance Antibodies Program April 16, 2009 By Catherine Hollingsworth No Comments
CTI Files Pixantrone NDA, Seeking Marketing Partner April 15, 2009 By Catherine Hollingsworth No Comments
NewCo News: GliaMed Gets a Facelift as it Moves into Wound Healing April 14, 2009 By Catherine Hollingsworth No Comments
Celldex Dusting Off Program Idled Years Ago by Amgen April 10, 2009 By Catherine Hollingsworth No Comments